Literature DB >> 6718689

The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: quantitative differences found using the radiation sensitizing agent misonidazole or oxygen.

C J Koch, C C Stobbe, E A Bump.   

Abstract

Pretreatment of V79- WNRE cells with 150 microM diethylmaleate for 1 hr at 37 degrees C caused a decrease in intracellular glutathione levels to approximately 10-15% of control levels (0.5 vs 5.0 nmol/10(6) cells). The cells could be washed free of diethylmaleate and held at 0 degree C for several hours without toxicity and with no increase in glutathione concentration, although the glutathione concentration rapidly increased to normal levels at higher temperatures. Survival curves were determined as a function of oxygen or misonidazole concentration (the latter in the absence of oxygen). A new "thin-film" technique was used to avoid changes in oxygen concentration because of radiochemical or cellular oxygen consumption. Glutathione depletion itself caused a small but consistent radiosensitization of hypoxic cells (dose enhancement ratio of 1.2). However, glutathione depletion caused a profound change in the radiosensitizing efficiency of misonidazole, with a decrease in Km of about sevenfold from 0.6 to 0.09 mM. In contrast, only a 2.5-fold decrease was found in the Km for radiosensitization by oxygen with diethylmaleate pretreatment. These results suggest a fundamental problem with the conventional theory of radiosensitivity whereby one considers a first-order competition for reaction with target radicals between radical-fixing versus radical-repairing species. It also suggests difficulties in the interpretation of glutathione as the only endogenous protective species.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6718689

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  11 in total

1.  Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.

Authors:  David J Carlson; Paul J Keall; Billy W Loo; Zhe J Chen; J Martin Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-22       Impact factor: 7.038

Review 2.  Redox properties and rate constants in free-radical mediated damage.

Authors:  P Wardman; E D Clarke
Journal:  Br J Cancer Suppl       Date:  1987-06

3.  Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation.

Authors:  D Vordermark; T Shibata; J M Brown
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

4.  Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations.

Authors:  S M Evans; R Lew; M L Kochman; E P Wileyto; E Baum; K M Safford; C J Koch
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

5.  pO(2)-dependent NO production determines OPPC activity in macrophages.

Authors:  Mary A Robinson; Stephen W Tuttle; Cynthia M Otto; Cameron J Koch
Journal:  Free Radic Biol Med       Date:  2009-10-12       Impact factor: 7.376

6.  Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.

Authors:  J A Raleigh; A J Franko; C J Koch; J L Born
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

7.  Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.

Authors:  K H Wong; C J Koch; C A Wallen; K T Wheeler
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

Review 8.  Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling.

Authors:  Annika Foehrenbacher; Timothy W Secomb; William R Wilson; Kevin O Hicks
Journal:  Front Oncol       Date:  2013-12-27       Impact factor: 6.244

9.  A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio.

Authors:  David Robert Grimes; Mike Partridge
Journal:  Biomed Phys Eng Express       Date:  2015-12-04

10.  First-In-Human Study in Cancer Patients Establishing the Feasibility of Oxygen Measurements in Tumors Using Electron Paramagnetic Resonance With the OxyChip.

Authors:  Philip E Schaner; Benjamin B Williams; Eunice Y Chen; Jason R Pettus; Wilson A Schreiber; Maciej M Kmiec; Lesley A Jarvis; David A Pastel; Rebecca A Zuurbier; Roberta M DiFlorio-Alexander; Joseph A Paydarfar; Benoit J Gosselin; Richard J Barth; Kari M Rosenkranz; Sergey V Petryakov; Huagang Hou; Dan Tse; Alexandre Pletnev; Ann Barry Flood; Victoria A Wood; Kendra A Hebert; Robyn E Mosher; Eugene Demidenko; Harold M Swartz; Periannan Kuppusamy
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.